Viewing Study NCT02380235


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2026-02-22 @ 12:50 PM
Study NCT ID: NCT02380235
Status: UNKNOWN
Last Update Posted: 2017-06-16
First Post: 2015-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children (Clinical Trial I)
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module